This is from a recent review on this molecule. More importantly, the anticancer aspect appears to be rather limited to certain cancer types.
Drug delivery platforms for Tanshinone IIA
Tan IIA is a lipophilic compound, as a result, it has poor bioavailability issues when used as drug [77]. Owing to their poor water solubility and poor dissolution issues, studies have shown that they exhibit robust first-pass effect and elimination through the liver following oral administration. Moreover, they are readily removed from circulation following intravenous administration, resulting in feeble shelf life. These aspects certainly present daunting challenges for their effective…
- Forums
- ASX - By Stock
- CPACS: Research, Results, Market Comparisons, and Valuations
This is from a recent review on this molecule. More importantly,...
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.69 |
Change
0.000(0.00%) |
Mkt cap ! $287.1M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 2348 | $1.69 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.68 | 200 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 2348 | 1.685 |
3 | 4099 | 1.680 |
1 | 597 | 1.675 |
1 | 2994 | 1.670 |
1 | 5077 | 1.660 |
Price($) | Vol. | No. |
---|---|---|
1.675 | 1968 | 1 |
1.680 | 200 | 1 |
1.685 | 5653 | 3 |
1.695 | 5 | 1 |
1.700 | 11100 | 2 |
Last trade - 10.01am 16/09/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |
Day chart unavailable
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online